Human papillomavirus (HPV) type distribution in Korean women: A meta-analysis

Journal of Microbiology and Biotechnology

Volumn 18, Issue 4, 2008, Pages 788-794

  Bae, Jeong Hoon ^a   Lee, Sung Jong ^a   Kim, Chan Joo ^a   Hur, Soo Young ^a   Park, Yong Gyu ^a   Lee, Won Chul ^a   Kim, Young Tak ^b   Ng, Timothy L ^c   Bock, Hans L ^c   Park, Jong Sup ^a  

^a The Catholic University of Korea   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia (CIN); Human papillomavirus (HPV); Polymerase chain reaction (PCR); Prevalence

Indexed keywords

WART VIRUS VACCINE; VIRUS DNA;

ARTICLE; BIBLIOGRAPHIC DATABASE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; KOREA; MAJOR CLINICAL STUDY; MIXED INFECTION; PAPILLOMA VIRUS; PREVALENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS; ALPHAPAPILLOMAVIRUS; CLASSIFICATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; GENETICS; ISOLATION AND PURIFICATION; META ANALYSIS; PATHOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

ALPHAPAPILLOMAVIRUS; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HUMANS; KOREA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POLYMERASE CHAIN REACTION;

EID: 48649098897     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. An, H. J., N. H. Cho, S. Y. Lee, L. H. Kim, C. Lee, S. J. Kim, M. S. Mun, S. H. Kim, J. K. Jeong. 2003. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97: 1672-1680.
2. Bao, Y. P., N. Li, J. S. Smith, Y. L. Qiao, and ACCPAB members. 2007. Human papillomavirus type distribution in women from Asia: A meta-analysis. Int. J. Gynecol. Cancer (In Press).
3. Cho, N. H., H. J. An, J. K. Jeong, S. Kang, J. W. Kim, Y. T. Kim, and T. K. Park. 2003. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: Comparison with cytologic diagnosis. Am. J. Gynecol. Oncol. 188; 56-62.
4. Clifford, G. M., J. S. Smith, M. Plummer, N. Muñoz, and S. Franceschi. 2003. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br. J. Cancer 88: 63-73.
5. Clifford, G. M., J. S. Smith, T. Aguado, and S. Franceschi. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br. J. Cancer 89: 101-105.
6. Clifford, G. M., R. K. Rana, S. Franceschi, J. S. Smith, G. Gough, and J. M. Pimenta. 2005. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol. Biomarkers Prev. 14: 1157-1164.
7. Clifford, G. M., S. Gallus, R. Herrero, N. Muñoz, P. J. Snijders, S. Vaccarella, P. T. Anh, C. Ferreccio, N. T. Hieu, E. Matos. M. Molano, R. Rajkumar, G. Ronco, S. de Sanjosé, H. R. Shin, S. Sukvirach, J. O. Thomas, S. Tunsakul, C. J. Meijer, S. Franceschi, and IARC HPV Prevalence Surveys Study Group. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 366: 991-998.
8. Hong, S. H., D. H. Lee, and H. R. Shin. 2004. Prevalence of human papillomavirus infection in women in South Korea: Incidence of positive HPV DNA and anti-VLPs in residense of Busan City. Korean J. Cytopathol. 15: 17-27.
9. Hwang, H. S., M. Park, S. Y. Lee, K. H. Kwon, and M. G. Pang. 2004. Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip. Cancer Epidemiol. Biomarkers Prev. 13: 2153-2156.
10. Hwang, T. 1999. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J. Korean Med. Sci. 14: 593-599.
11. Hwang, T. S., J. K. Jeong, M. Park, H. S. Han, H. K. Choi, and T. S. Park. 2003. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol. Oncol. 90: 51-56.
12. Jacobs, M. V., A. M. De Roda Husman, A. J. C. Van Den Brule, P. J. F. Snijders, C. J. L. M. Meijer, and J. M. M. Walboomers. 1995. Group-specific differentiation between high-and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J. Clin. Microbiol. 33: 901-905.
13. Kim. C. J. J. K. Jeong. M. Park, T. S. Park. T. C. Park, ??? Nam??????, and J. S. Park. 2003. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol. Oncol. 89: 210-217.
14. Kleter, B., L. V. Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, J. T. Schegget, J. Lindeman, B. T. Harmsel, M. Burger, and W. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37: 2508-2517.
15. Lee, G.Y., S. M. Kim, S. Y. Rim, H. S. Choi, C. S. Park, and J. H. Nam. 2005. Human papillomavirus (HPV) genotyping by HPV DNA chip in cervical cancer and precancerous lesions. Int. J. Gynecol. Cancer 15: 81-87.
16. Lee, H. S., K. M. Kim, S. M. Kim, Y. D. Choi, J. H. Nam, C. S. Park, and H. S. Choi. 2007. Human papillomavirus genotyping using HPV DNA chip analysis in Korean women. Int. J. Gynecol. Cancer 17: 497-501.
17. Lee, S. A., D. Kang, S. S. Seo, J. K. Jeong, K. Y. You, Y. T. Jeon, J. W. Kim, N. H. Park, S. B. Kang, H. P. Lee, and Y. S. Song. 2003. Multiple HPV infection in cervical cancer screened by HPV DNAChip. Cancer Lett. 198: 187-192.
18. Oh, Y. L., K. J. Shin, J. Han, and D. S. Kim. 2001. Significance of high-risk human papillomavirus detection by polymerase chain reaction in primary cervical cancer screening. Cytopathology 12: 75-83.
19. Paavonen, J., D. Jenkins, F. X. Bosch, P. Naud, J. Salmerón, C. M. Wheeler, S. N. Chow, D. L. Apter, H. C. Kitchener, et al. study group. 2007. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369: 2161-2170.
20. Park, H. K., Y. M. Kang, J. M. Park Y. J. Choi, Y. N. Kim, D. H. Jeong, and K. T. Kim. 2003. Prevalence and genotyping of HPV in different grades of cervical intraepithelial neoplasia and cervical cancer. Korean J. Gynecol. Oncol. Colposc. 14: 123-132.
21. Park, H. K., Y. N. Kim, D. H. Jeong, K. B. Lee, M. S. Sung, and K. T. Kim. 2005. Human papillomavirus (HPV) in lymphatic fluid of patients with cervical cancer. Korean J. Gynecol. Oncol. 16: 61-69.
22. Park, T. C., C. J. Kim, Y. M. Koh, K. H. Lee, J. H. Yoon, J. H. Kim, S. E. Namkoong, and J. S. Park. 2004. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol. 23: 119-125.
23. Seo, S. S., Y. S. Song, J. W. Kim, N. H. Park, S. B. Kang, and H. P. Lee. 2006. Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleotide microarray. Gynecol. Oncol. 102: 67-73.
24. Shin, H. R., D. H. Lee, R. Herrero, J. S. Smith, S. Vaccarella, S. H. Hong, K. Y. Jung, H. H. Kim, U. D. Park, H. S. Cha, S. Park, A. Touzé, N. Muñoz, P. J. Snijders, C. J. Meijer, P. Coursaget, and S. Franceschi. 2003. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int. J. Cancer 103: 413-421.
25. Shin, H. R., S. Franceschi, S. Vaccarella, J. W. Roh, Y. H. Ju, J. K. Oh, H. J. Kong, S. H. Rha, S. I. Jung, et al. 2004. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J. Infect. Dis. 190: 468-476.
26. Song, E. S., H. J. Lee, and T. S. Hwang. 2007. Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions. J. Korean Med. Sci. 22: 99-104.
27. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Muñoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189: 12-19.